# Keros Therapeutics, Inc. (KROS) insider trading, Q3 2026

Canonical: https://sec-api.dev/insider-trading/kros

> 7 non-derivative transactions: 2 purchases ($21K), 4 sales ($101K). CIK 1664710.

| Date | Insider | Relationship | Code | Shares | Price | Owned after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-08-18 | Newton Charles W. | Director | S | 551.0 | 10.3 | 12114.0 | https://www.sec.gov/Archives/edgar/data/1664710/000186621926000010/0001866219-26-000010-index.htm |
| 2026-08-18 | Lerner Lorena Raquel | Officer | S | 3568.0 | 10.29 | 27559.0 | https://www.sec.gov/Archives/edgar/data/1664710/000208135926000008/0002081359-26-000008-index.htm |
| 2026-08-18 | Cho Esther | Officer | S | 4485.0 | 10.29 | 35770.0 | https://www.sec.gov/Archives/edgar/data/1664710/000208146026000009/0002081460-26-000009-index.htm |
| 2026-08-18 | Tanini Annita | Officer | S | 1224.0 | 10.29 | 45144.0 | https://www.sec.gov/Archives/edgar/data/1664710/000214678426000004/0002146784-26-000004-index.htm |
| 2026-08-17 | BIENAIME JEAN JACQUES | Director | P | 1000.0 | 10.27 | 19592.0 | https://www.sec.gov/Archives/edgar/data/1664710/000122159026000025/0001221590-26-000025-index.htm |
| 2026-07-15 | BIENAIME JEAN JACQUES | Director | P | 1000.0 | 10.61 | 18592.0 | https://www.sec.gov/Archives/edgar/data/1664710/000122159026000023/0001221590-26-000023-index.htm |
| 2026-07-01 | Prener Anne | Director | A | 13786.0 | 0.0 | 13786.0 | https://www.sec.gov/Archives/edgar/data/1664710/000179791726000007/0001797917-26-000007-index.htm |

Source: https://www.sec.gov/data-research/sec-markets-data/insider-transactions-data-sets

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.
API: https://sec-api.dev/docs · ChatGPT app: https://chatgpt.com/plugins/plugin_asdk_app_6ae0ef2436ac8191941dae8a4d732669 · Free key: https://sec-api.dev/sign-up